Pharma & Healthcare
Global Inhaled Nitric Oxide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198455
- Pages: 71
- Figures: 75
- Views: 28
The global Inhaled Nitric Oxide market size was US$ 1270 million in 2024 and is forecast to a readjusted size of US$ 2202 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
The global Inhaled Nitric Oxide market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
By Type: (Dominant Segment vs High-Margin Innovation)
800 ppm
100 ppm
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Mallinckrodt in Europe)
- Emerging Product Trends: 800 ppm adoption vs. 100 ppm premiumization
- Demand-Side Dynamics: Near-term and Pre-term Infants PPHN growth in China vs. Children and Adult ARDS potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Inhaled Nitric Oxide market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 100 ppm in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Children and Adult ARDS in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 800 ppm dominance in Europe vs. 100 ppm demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
The global Inhaled Nitric Oxide market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
By Type: (Dominant Segment vs High-Margin Innovation)
800 ppm
100 ppm
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Mallinckrodt in Europe)
- Emerging Product Trends: 800 ppm adoption vs. 100 ppm premiumization
- Demand-Side Dynamics: Near-term and Pre-term Infants PPHN growth in China vs. Children and Adult ARDS potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Inhaled Nitric Oxide market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 100 ppm in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Children and Adult ARDS in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 800 ppm dominance in Europe vs. 100 ppm demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Inhaled Nitric Oxide Product Scope
1.2 Inhaled Nitric Oxide by Type
1.2.1 Global Inhaled Nitric Oxide Sales by Type (2020 & 2024 & 2031)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Inhaled Nitric Oxide by Application
1.3.1 Global Inhaled Nitric Oxide Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Near-term and Pre-term Infants PPHN
1.3.3 Children and Adult ARDS
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Estimates and Forecasts (2020-2031)
1.4.1 Global Inhaled Nitric Oxide Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Inhaled Nitric Oxide Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Inhaled Nitric Oxide Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Inhaled Nitric Oxide Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Inhaled Nitric Oxide Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
2.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2025)
2.3 Global Inhaled Nitric Oxide Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Inhaled Nitric Oxide Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Inhaled Nitric Oxide Market Size and Prospective (2020-2031)
2.4.2 Europe Inhaled Nitric Oxide Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Inhaled Nitric Oxide Historic Market Review by Type (2020-2025)
3.1.1 Global Inhaled Nitric Oxide Sales by Type (2020-2025)
3.1.2 Global Inhaled Nitric Oxide Revenue by Type (2020-2025)
3.1.3 Global Inhaled Nitric Oxide Price by Type (2020-2025)
3.2 Global Inhaled Nitric Oxide Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Inhaled Nitric Oxide Sales Forecast by Type (2026-2031)
3.2.2 Global Inhaled Nitric Oxide Revenue Forecast by Type (2026-2031)
3.2.3 Global Inhaled Nitric Oxide Price Forecast by Type (2026-2031)
3.3 Different Types Inhaled Nitric Oxide Representative Players
4 Global Market Size by Application
4.1 Global Inhaled Nitric Oxide Historic Market Review by Application (2020-2025)
4.1.1 Global Inhaled Nitric Oxide Sales by Application (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Revenue by Application (2020-2025)
4.1.3 Global Inhaled Nitric Oxide Price by Application (2020-2025)
4.2 Global Inhaled Nitric Oxide Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Inhaled Nitric Oxide Sales Forecast by Application (2026-2031)
4.2.2 Global Inhaled Nitric Oxide Revenue Forecast by Application (2026-2031)
4.2.3 Global Inhaled Nitric Oxide Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Inhaled Nitric Oxide Application
5 Competition Landscape by Players
5.1 Global Inhaled Nitric Oxide Sales by Players (2020-2025)
5.2 Global Top Inhaled Nitric Oxide Players by Revenue (2020-2025)
5.3 Global Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
5.4 Global Inhaled Nitric Oxide Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
5.7 Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Inhaled Nitric Oxide Sales by Company
6.1.1.1 North America Inhaled Nitric Oxide Sales by Company (2020-2025)
6.1.1.2 North America Inhaled Nitric Oxide Revenue by Company (2020-2025)
6.1.2 North America Inhaled Nitric Oxide Sales Breakdown by Type (2020-2025)
6.1.3 North America Inhaled Nitric Oxide Sales Breakdown by Application (2020-2025)
6.1.4 North America Inhaled Nitric Oxide Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Inhaled Nitric Oxide Sales by Company
6.2.1.1 Europe Inhaled Nitric Oxide Sales by Company (2020-2025)
6.2.1.2 Europe Inhaled Nitric Oxide Revenue by Company (2020-2025)
6.2.2 Europe Inhaled Nitric Oxide Sales Breakdown by Type (2020-2025)
6.2.3 Europe Inhaled Nitric Oxide Sales Breakdown by Application (2020-2025)
6.2.4 Europe Inhaled Nitric Oxide Major Customer
6.2.5 Europe Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Information
7.1.2 Mallinckrodt Business Overview
7.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Mallinckrodt Inhaled Nitric Oxide Products Offered
7.1.5 Mallinckrodt Recent Development
7.2 Praxair (Linde plc)
7.2.1 Praxair (Linde plc) Company Information
7.2.2 Praxair (Linde plc) Business Overview
7.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Products Offered
7.2.5 Praxair (Linde plc) Recent Development
7.3 Air Liquide
7.3.1 Air Liquide Company Information
7.3.2 Air Liquide Business Overview
7.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Air Liquide Inhaled Nitric Oxide Products Offered
7.3.5 Air Liquide Recent Development
7.4 BOC Healthcare (Linde Group)
7.4.1 BOC Healthcare (Linde Group) Company Information
7.4.2 BOC Healthcare (Linde Group) Business Overview
7.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Products Offered
7.4.5 BOC Healthcare (Linde Group) Recent Development
8 Inhaled Nitric Oxide Manufacturing Cost Analysis
8.1 Inhaled Nitric Oxide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Inhaled Nitric Oxide
8.4 Inhaled Nitric Oxide Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Inhaled Nitric Oxide Distributors List
9.3 Inhaled Nitric Oxide Customers
10 Inhaled Nitric Oxide Market Dynamics
10.1 Inhaled Nitric Oxide Industry Trends
10.2 Inhaled Nitric Oxide Market Drivers
10.3 Inhaled Nitric Oxide Market Challenges
10.4 Inhaled Nitric Oxide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Inhaled Nitric Oxide Product Scope
1.2 Inhaled Nitric Oxide by Type
1.2.1 Global Inhaled Nitric Oxide Sales by Type (2020 & 2024 & 2031)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Inhaled Nitric Oxide by Application
1.3.1 Global Inhaled Nitric Oxide Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Near-term and Pre-term Infants PPHN
1.3.3 Children and Adult ARDS
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Estimates and Forecasts (2020-2031)
1.4.1 Global Inhaled Nitric Oxide Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Inhaled Nitric Oxide Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Inhaled Nitric Oxide Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Inhaled Nitric Oxide Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Inhaled Nitric Oxide Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
2.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2025)
2.3 Global Inhaled Nitric Oxide Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Inhaled Nitric Oxide Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Inhaled Nitric Oxide Market Size and Prospective (2020-2031)
2.4.2 Europe Inhaled Nitric Oxide Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Inhaled Nitric Oxide Historic Market Review by Type (2020-2025)
3.1.1 Global Inhaled Nitric Oxide Sales by Type (2020-2025)
3.1.2 Global Inhaled Nitric Oxide Revenue by Type (2020-2025)
3.1.3 Global Inhaled Nitric Oxide Price by Type (2020-2025)
3.2 Global Inhaled Nitric Oxide Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Inhaled Nitric Oxide Sales Forecast by Type (2026-2031)
3.2.2 Global Inhaled Nitric Oxide Revenue Forecast by Type (2026-2031)
3.2.3 Global Inhaled Nitric Oxide Price Forecast by Type (2026-2031)
3.3 Different Types Inhaled Nitric Oxide Representative Players
4 Global Market Size by Application
4.1 Global Inhaled Nitric Oxide Historic Market Review by Application (2020-2025)
4.1.1 Global Inhaled Nitric Oxide Sales by Application (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Revenue by Application (2020-2025)
4.1.3 Global Inhaled Nitric Oxide Price by Application (2020-2025)
4.2 Global Inhaled Nitric Oxide Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Inhaled Nitric Oxide Sales Forecast by Application (2026-2031)
4.2.2 Global Inhaled Nitric Oxide Revenue Forecast by Application (2026-2031)
4.2.3 Global Inhaled Nitric Oxide Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Inhaled Nitric Oxide Application
5 Competition Landscape by Players
5.1 Global Inhaled Nitric Oxide Sales by Players (2020-2025)
5.2 Global Top Inhaled Nitric Oxide Players by Revenue (2020-2025)
5.3 Global Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
5.4 Global Inhaled Nitric Oxide Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
5.7 Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Inhaled Nitric Oxide Sales by Company
6.1.1.1 North America Inhaled Nitric Oxide Sales by Company (2020-2025)
6.1.1.2 North America Inhaled Nitric Oxide Revenue by Company (2020-2025)
6.1.2 North America Inhaled Nitric Oxide Sales Breakdown by Type (2020-2025)
6.1.3 North America Inhaled Nitric Oxide Sales Breakdown by Application (2020-2025)
6.1.4 North America Inhaled Nitric Oxide Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Inhaled Nitric Oxide Sales by Company
6.2.1.1 Europe Inhaled Nitric Oxide Sales by Company (2020-2025)
6.2.1.2 Europe Inhaled Nitric Oxide Revenue by Company (2020-2025)
6.2.2 Europe Inhaled Nitric Oxide Sales Breakdown by Type (2020-2025)
6.2.3 Europe Inhaled Nitric Oxide Sales Breakdown by Application (2020-2025)
6.2.4 Europe Inhaled Nitric Oxide Major Customer
6.2.5 Europe Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Information
7.1.2 Mallinckrodt Business Overview
7.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Mallinckrodt Inhaled Nitric Oxide Products Offered
7.1.5 Mallinckrodt Recent Development
7.2 Praxair (Linde plc)
7.2.1 Praxair (Linde plc) Company Information
7.2.2 Praxair (Linde plc) Business Overview
7.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Products Offered
7.2.5 Praxair (Linde plc) Recent Development
7.3 Air Liquide
7.3.1 Air Liquide Company Information
7.3.2 Air Liquide Business Overview
7.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Air Liquide Inhaled Nitric Oxide Products Offered
7.3.5 Air Liquide Recent Development
7.4 BOC Healthcare (Linde Group)
7.4.1 BOC Healthcare (Linde Group) Company Information
7.4.2 BOC Healthcare (Linde Group) Business Overview
7.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
7.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Products Offered
7.4.5 BOC Healthcare (Linde Group) Recent Development
8 Inhaled Nitric Oxide Manufacturing Cost Analysis
8.1 Inhaled Nitric Oxide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Inhaled Nitric Oxide
8.4 Inhaled Nitric Oxide Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Inhaled Nitric Oxide Distributors List
9.3 Inhaled Nitric Oxide Customers
10 Inhaled Nitric Oxide Market Dynamics
10.1 Inhaled Nitric Oxide Industry Trends
10.2 Inhaled Nitric Oxide Market Drivers
10.3 Inhaled Nitric Oxide Market Challenges
10.4 Inhaled Nitric Oxide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Inhaled Nitric Oxide Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Inhaled Nitric Oxide Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Inhaled Nitric Oxide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Inhaled Nitric Oxide Sales (M L) by Region (2020-2025)
Table 5. Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
Table 6. Global Inhaled Nitric Oxide Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Inhaled Nitric Oxide Revenue Share by Region (2020-2025)
Table 8. Global Inhaled Nitric Oxide Sales (M L) Forecast by Region (2026-2031)
Table 9. Global Inhaled Nitric Oxide Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Inhaled Nitric Oxide Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Inhaled Nitric Oxide Revenue Share Forecast by Region (2026-2031)
Table 12. Global Inhaled Nitric Oxide Sales by Type (M L) & (2020-2025)
Table 13. Global Inhaled Nitric Oxide Sales Share by Type (2020-2025)
Table 14. Global Inhaled Nitric Oxide Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Inhaled Nitric Oxide Price by Type (US$/L) & (2020-2025)
Table 16. Global Inhaled Nitric Oxide Sales by Type (M L) & (2026-2031)
Table 17. Global Inhaled Nitric Oxide Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Inhaled Nitric Oxide Price by Type (US$/L) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Inhaled Nitric Oxide Sales by Application (M L) & (2020-2025)
Table 21. Global Inhaled Nitric Oxide Sales Share by Application (2020-2025)
Table 22. Global Inhaled Nitric Oxide Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Inhaled Nitric Oxide Price by Application (US$/L) & (2020-2025)
Table 24. Global Inhaled Nitric Oxide Sales by Application (M L) & (2026-2031)
Table 25. Global Inhaled Nitric Oxide Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Inhaled Nitric Oxide Price by Application (US$/L) & (2026-2031)
Table 27. New Sources of Growth in Inhaled Nitric Oxide Application
Table 28. Global Inhaled Nitric Oxide Sales by Company (M L) & (2020-2025)
Table 29. Global Inhaled Nitric Oxide Sales Share by Company (2020-2025)
Table 30. Global Inhaled Nitric Oxide Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Inhaled Nitric Oxide Revenue Share by Company (2020-2025)
Table 32. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
Table 33. Global Market Inhaled Nitric Oxide Average Price by Company (US$/L) & (2020-2025)
Table 34. Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
Table 36. Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Inhaled Nitric Oxide Sales by Company (2020-2025) & (M L)
Table 39. North America Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
Table 40. North America Inhaled Nitric Oxide Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
Table 42. North America Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 43. North America Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 44. North America Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 45. North America Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Table 46. Europe Inhaled Nitric Oxide Sales by Company (2020-2025) & (M L)
Table 47. Europe Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
Table 48. Europe Inhaled Nitric Oxide Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
Table 50. Europe Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 51. Europe Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 52. Europe Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 53. Europe Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Table 54. Mallinckrodt Company Information
Table 55. Mallinckrodt Description and Business Overview
Table 56. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 57. Mallinckrodt Inhaled Nitric Oxide Product
Table 58. Mallinckrodt Recent Development
Table 59. Praxair (Linde plc) Company Information
Table 60. Praxair (Linde plc) Description and Business Overview
Table 61. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 62. Praxair (Linde plc) Inhaled Nitric Oxide Product
Table 63. Praxair (Linde plc) Recent Development
Table 64. Air Liquide Company Information
Table 65. Air Liquide Description and Business Overview
Table 66. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 67. Air Liquide Inhaled Nitric Oxide Product
Table 68. Air Liquide Recent Development
Table 69. BOC Healthcare (Linde Group) Company Information
Table 70. BOC Healthcare (Linde Group) Description and Business Overview
Table 71. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 72. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product
Table 73. BOC Healthcare (Linde Group) Recent Development
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Inhaled Nitric Oxide Distributors List
Table 77. Inhaled Nitric Oxide Customers List
Table 78. Inhaled Nitric Oxide Market Trends
Table 79. Inhaled Nitric Oxide Market Drivers
Table 80. Inhaled Nitric Oxide Market Challenges
Table 81. Inhaled Nitric Oxide Market Restraints
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled Nitric Oxide Product Picture
Figure 2. Global Inhaled Nitric Oxide Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Inhaled Nitric Oxide Sales Market Share by Type in 2024 & 2031
Figure 4. 800 ppm Product Picture
Figure 5. 100 ppm Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhaled Nitric Oxide Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Inhaled Nitric Oxide Sales Market Share by Application in 2024 & 2031
Figure 9. Near-term and Pre-term Infants PPHN Examples
Figure 10. Children and Adult ARDS Examples
Figure 11. Other Diseases Examples
Figure 12. Global Inhaled Nitric Oxide Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inhaled Nitric Oxide Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Inhaled Nitric Oxide Sales (M L) Growth Rate (2020-2031)
Figure 15. Global Inhaled Nitric Oxide Price Trends Growth Rate (2020-2031) & (US$/L)
Figure 16. Inhaled Nitric Oxide Report Years Considered
Figure 17. Global Market Inhaled Nitric Oxide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Inhaled Nitric Oxide Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Inhaled Nitric Oxide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Inhaled Nitric Oxide Sales (M L) Growth Rate (2020-2031)
Figure 21. Europe Inhaled Nitric Oxide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Inhaled Nitric Oxide Sales (M L) Growth Rate (2020-2031)
Figure 23. Global Inhaled Nitric Oxide Revenue Share by Type (2020-2025)
Figure 24. Global Inhaled Nitric Oxide Sales Share by Type (2026-2031)
Figure 25. Global Inhaled Nitric Oxide Revenue Share by Type (2026-2031)
Figure 26. Global Inhaled Nitric Oxide Revenue Share by Application (2020-2025)
Figure 27. Global Inhaled Nitric Oxide Revenue Growth Rate by Application in 2020 & 2024
Figure 28. Global Inhaled Nitric Oxide Sales Share by Application (2026-2031)
Figure 29. Global Inhaled Nitric Oxide Revenue Share by Application (2026-2031)
Figure 30. Global Inhaled Nitric Oxide Sales Share by Company (2024)
Figure 31. Global Inhaled Nitric Oxide Revenue Share by Company (2024)
Figure 32. Global 5 Largest Inhaled Nitric Oxide Players Market Share by Revenue in Inhaled Nitric Oxide: 2020 & 2024
Figure 33. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Manufacturing Cost Structure of Inhaled Nitric Oxide
Figure 35. Manufacturing Process Analysis of Inhaled Nitric Oxide
Figure 36. Inhaled Nitric Oxide Industrial Chain
Figure 37. Channels of Distribution (Direct Vs Distribution)
Figure 38. Distributors Profiles
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Table 1. Global Inhaled Nitric Oxide Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Inhaled Nitric Oxide Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Inhaled Nitric Oxide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Inhaled Nitric Oxide Sales (M L) by Region (2020-2025)
Table 5. Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
Table 6. Global Inhaled Nitric Oxide Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Inhaled Nitric Oxide Revenue Share by Region (2020-2025)
Table 8. Global Inhaled Nitric Oxide Sales (M L) Forecast by Region (2026-2031)
Table 9. Global Inhaled Nitric Oxide Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Inhaled Nitric Oxide Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Inhaled Nitric Oxide Revenue Share Forecast by Region (2026-2031)
Table 12. Global Inhaled Nitric Oxide Sales by Type (M L) & (2020-2025)
Table 13. Global Inhaled Nitric Oxide Sales Share by Type (2020-2025)
Table 14. Global Inhaled Nitric Oxide Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Inhaled Nitric Oxide Price by Type (US$/L) & (2020-2025)
Table 16. Global Inhaled Nitric Oxide Sales by Type (M L) & (2026-2031)
Table 17. Global Inhaled Nitric Oxide Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Inhaled Nitric Oxide Price by Type (US$/L) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Inhaled Nitric Oxide Sales by Application (M L) & (2020-2025)
Table 21. Global Inhaled Nitric Oxide Sales Share by Application (2020-2025)
Table 22. Global Inhaled Nitric Oxide Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Inhaled Nitric Oxide Price by Application (US$/L) & (2020-2025)
Table 24. Global Inhaled Nitric Oxide Sales by Application (M L) & (2026-2031)
Table 25. Global Inhaled Nitric Oxide Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Inhaled Nitric Oxide Price by Application (US$/L) & (2026-2031)
Table 27. New Sources of Growth in Inhaled Nitric Oxide Application
Table 28. Global Inhaled Nitric Oxide Sales by Company (M L) & (2020-2025)
Table 29. Global Inhaled Nitric Oxide Sales Share by Company (2020-2025)
Table 30. Global Inhaled Nitric Oxide Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Inhaled Nitric Oxide Revenue Share by Company (2020-2025)
Table 32. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
Table 33. Global Market Inhaled Nitric Oxide Average Price by Company (US$/L) & (2020-2025)
Table 34. Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
Table 36. Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Inhaled Nitric Oxide Sales by Company (2020-2025) & (M L)
Table 39. North America Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
Table 40. North America Inhaled Nitric Oxide Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
Table 42. North America Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 43. North America Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 44. North America Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 45. North America Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Table 46. Europe Inhaled Nitric Oxide Sales by Company (2020-2025) & (M L)
Table 47. Europe Inhaled Nitric Oxide Sales Market Share by Company (2020-2025)
Table 48. Europe Inhaled Nitric Oxide Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
Table 50. Europe Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 51. Europe Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 52. Europe Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 53. Europe Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Table 54. Mallinckrodt Company Information
Table 55. Mallinckrodt Description and Business Overview
Table 56. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 57. Mallinckrodt Inhaled Nitric Oxide Product
Table 58. Mallinckrodt Recent Development
Table 59. Praxair (Linde plc) Company Information
Table 60. Praxair (Linde plc) Description and Business Overview
Table 61. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 62. Praxair (Linde plc) Inhaled Nitric Oxide Product
Table 63. Praxair (Linde plc) Recent Development
Table 64. Air Liquide Company Information
Table 65. Air Liquide Description and Business Overview
Table 66. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 67. Air Liquide Inhaled Nitric Oxide Product
Table 68. Air Liquide Recent Development
Table 69. BOC Healthcare (Linde Group) Company Information
Table 70. BOC Healthcare (Linde Group) Description and Business Overview
Table 71. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 72. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product
Table 73. BOC Healthcare (Linde Group) Recent Development
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Inhaled Nitric Oxide Distributors List
Table 77. Inhaled Nitric Oxide Customers List
Table 78. Inhaled Nitric Oxide Market Trends
Table 79. Inhaled Nitric Oxide Market Drivers
Table 80. Inhaled Nitric Oxide Market Challenges
Table 81. Inhaled Nitric Oxide Market Restraints
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled Nitric Oxide Product Picture
Figure 2. Global Inhaled Nitric Oxide Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Inhaled Nitric Oxide Sales Market Share by Type in 2024 & 2031
Figure 4. 800 ppm Product Picture
Figure 5. 100 ppm Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhaled Nitric Oxide Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Inhaled Nitric Oxide Sales Market Share by Application in 2024 & 2031
Figure 9. Near-term and Pre-term Infants PPHN Examples
Figure 10. Children and Adult ARDS Examples
Figure 11. Other Diseases Examples
Figure 12. Global Inhaled Nitric Oxide Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inhaled Nitric Oxide Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Inhaled Nitric Oxide Sales (M L) Growth Rate (2020-2031)
Figure 15. Global Inhaled Nitric Oxide Price Trends Growth Rate (2020-2031) & (US$/L)
Figure 16. Inhaled Nitric Oxide Report Years Considered
Figure 17. Global Market Inhaled Nitric Oxide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Inhaled Nitric Oxide Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Inhaled Nitric Oxide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Inhaled Nitric Oxide Sales (M L) Growth Rate (2020-2031)
Figure 21. Europe Inhaled Nitric Oxide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Inhaled Nitric Oxide Sales (M L) Growth Rate (2020-2031)
Figure 23. Global Inhaled Nitric Oxide Revenue Share by Type (2020-2025)
Figure 24. Global Inhaled Nitric Oxide Sales Share by Type (2026-2031)
Figure 25. Global Inhaled Nitric Oxide Revenue Share by Type (2026-2031)
Figure 26. Global Inhaled Nitric Oxide Revenue Share by Application (2020-2025)
Figure 27. Global Inhaled Nitric Oxide Revenue Growth Rate by Application in 2020 & 2024
Figure 28. Global Inhaled Nitric Oxide Sales Share by Application (2026-2031)
Figure 29. Global Inhaled Nitric Oxide Revenue Share by Application (2026-2031)
Figure 30. Global Inhaled Nitric Oxide Sales Share by Company (2024)
Figure 31. Global Inhaled Nitric Oxide Revenue Share by Company (2024)
Figure 32. Global 5 Largest Inhaled Nitric Oxide Players Market Share by Revenue in Inhaled Nitric Oxide: 2020 & 2024
Figure 33. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 34. Manufacturing Cost Structure of Inhaled Nitric Oxide
Figure 35. Manufacturing Process Analysis of Inhaled Nitric Oxide
Figure 36. Inhaled Nitric Oxide Industrial Chain
Figure 37. Channels of Distribution (Direct Vs Distribution)
Figure 38. Distributors Profiles
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232